Science Lobby Seeks Funds

WASHINGTON—A clearer focus and greater financial support from private industry hold the key to the survival of the National Coalition for Science and Technology. The Coalition, formed in 1981, has struggled to persuade the scientific community that it needs an overtly political organization to advocate greater resources for science. Its new slogan, “NCST—The Science Lobby,” is meant to highlight its broad focus and set it apart from the hundreds of associations and orga

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—A clearer focus and greater financial support from private industry hold the key to the survival of the National Coalition for Science and Technology. The Coalition, formed in 1981, has struggled to persuade the scientific community that it needs an overtly political organization to advocate greater resources for science. Its new slogan, “NCST—The Science Lobby,” is meant to highlight its broad focus and set it apart from the hundreds of associations and organizations that push for specific programs. “We're trying to build a paradigm that is foreign to most scientists,” acknowledged Donald Stein, a neuroscientist at Clark University who helped to found the Coalition after serving a one-year fellowship on the Hill. “But I'd like to know what's wrong or inappropriate with direct lobbying to change the minds of the people who make the decisions.” That approach caused a problem for the American Chemical Society, whose governing body voted last ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies